Your current location:Home>>About KBI>>Milestones
ABOUT US

Kunming Biomed International (KBI) is science-based pharmacology and technology platform company that provides non-human primate-based preclinical services. KBI is primarily invested by the Morningside Group which is a private investment group founded in 1986 in Boston by the Chan family of Hong Kong.


Copyright © 2022 Kunming Biomed International Ltd. All Rights Reserved     |Privacy Policy|Terms of Use|
4571 Boda Road, Chenggong, Kunming, Yunnan, 650500, China